Vaccine development remains central to reducing incident HIV globally, particularly where long-acting PrEP access is limited, ...
Jody L. Green, PhD, explains how regulatory decisions shape medication safety amid uptake of OTC drugs. Green also highlights ...
These results suggest that ruxolitinib cream offers high levels of clinical efficacy, including deep and rapid responses, ...
For Patients With mCRPC, Results With Pluvicto in Real-World Settings Keep Pace With Clinical Trials
Real-world evidence shows Pluvicto matches pivotal trial benefits in PSMA-positive mCRPC, with longer PFS after one ARPI and delayed chemotherapy.
Povorcitinib 75 mg achieved high-threshold lesion clearance by week 12, including 100% draining-tunnel reduction in 12%–57% and total abscess clearance in 22%–62% of participants. Phase 3 data show ...
A retrospective registry analysis linked ischemic and hemorrhagic strokes to pollutant levels on the event day and prior two days to reflect delayed physiologic effects. Ozone spikes (peak 136 ppb vs ...
Despite these declines, CRC incidence is rising in adults younger than 65, increasing by 3% per year among patients aged 20 to 49 years and 0.4% per year among those aged 50 to 64 years. Consequently, ...
The gap in shared decision-making was similarly notable. Clinicians rated their own effectiveness in involving patients at 80.8 out of 100, while patients rated clinician involvement at only 69.1.
Advanced practice providers expand access by conducting initial consults, ordering diagnostic workups, explaining anti-amyloid risk–benefit tradeoffs, and coordinating multidisciplinary stakeholders ...
AI-enabled coronary CT angiography reveals total plaque burden beyond calcium scores, improving risk prediction and personalizing cardiovascular prevention.
AJMC: Your findings suggest that roughly 1 in 10 Medicare Advantage enrollees may face forced disenrollment in 2026. From a ...
As employers grapple with the soaring demand for glucagon-like peptide-1 (GLP-1) medications, Eric Levin, CEO and cofounder ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results